Nomura Holdings
RVMD icon

Nomura Holdings’s Revolution Medicines RVMD Stock Holding History

Nomura Holdings’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-58,900
Closed -$2.17M – 2051
2025
Q2 		$2.17M Buy
+58,900
New +$2.26M ﹤0.01% 819

Other funds holding RVMD

FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Nomura Holdings's RVMD Position: Q1 2026 in Review

Nomura Holdings opened a new position in Revolution Medicines (RVMD) in Q1 2026: 17,359 shares worth $1.69M. The stake represents ﹤0.01% of the portfolio and ranks #980 among its holdings.

512 funds tracked by Wall St. Rank hold RVMD as of Q1 2026.

  • Nomura Holdings held 17,359 shares of Revolution Medicines worth $1.69M as of Q1 2026.
  • Revolution Medicines was a new Nomura Holdings position in Q1 2026.
  • Revolution Medicines made up ﹤0.01% of Nomura Holdings's portfolio in Q1 2026, its #980 holding.
  • 512 funds tracked by Wall St. Rank held Revolution Medicines as of Q1 2026.

Based on Nomura Holdings's 13F filing for Q1 2026, filed 15 May 2026.